
A · NYSE
Agilent Technologies, Inc.
$173.07 -0.83 (-0.48%)
Company overview
Agilent Technologies, Inc. provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components, liquid chromatography mass spectrometry systems, gas chromatography systems and components, gas chromatography mass spectrometry systems, inductively coupled plasma mass spectrometry instruments, atomic absorption instruments, microwave plasma-atomic emission spectrometry instruments, inductively coupled plasma optical emission spectrometry instruments, Raman spectroscopy, cell analysis plate-based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, laboratory software, information management and analytics, laboratory automation and robotic systems, dissolution testing, vacuum pumps, and measurement technologie…
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Exchange
- NYSE
- Market cap
- $48.8B
- Employees
- 17,900
- Headquarters
- Santa Clara, CA
- Website
- agilent.com
- CEO
- Padraig McDonnell
- Listed
- November 18, 1999
- P/E
- 34.68
- Dividend yield
- 0.60%
Company financials
- Revenue
- $7.2B
- Gross profit
- $3.8B
- Operating income
- $1.6B
- EBITDA
- $1.9B
- Net income
- $1.4B
- EPS
- $4.99
- Total assets
- $13.1B
- Total debt
- $3.4B
- Gross margin
- 53.00%
- Net margin
- 19.55%
- Earnings yield
- 2.88%
Showing FY 2025